| An economic model of the long-term health care burden of Type II diabetes. | |
| | |
MedLine Citation:
|
PMID: 11793015 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS/HYPOTHESIS: To develop a long-term economic model of health care for Type II diabetes initially for the United Kingdom; characterize experiences of diabetes-related morbidities and the use of health care resources among a typical Type II diabetes cohort; to estimate lifetime differences in expected health outcomes and costs attributable to Type II diabetes; and to facilitate evaluation of policies or interventions in treating Type II diabetes from the funder's perspective. METHODS: A compact spreadsheet structure of interconnected Markov chain modules was developed to facilitate rapid estimation of costs and outcomes for whole populations. Recent clinical findings from the United Kingdom Prospective Diabetes Study and other sources were incorporated and a detailed costing module developed from United Kingdom observational data. RESULTS: The model allows the assessment of costs and long-term complications experienced by people suffering from Type II diabetes, including direct health care costs associated with the main diabetic complications and second-order effects on other health services required by such patients. Initial results suggest that the lifetime cost of health care for patients from the diagnosis of diabetes is more than double that for an equivalent non-diabetic population. CONCLUSION/INTERPRETATION: The model is intended for use by health care policy makers and payers to assess the long-term budgetary impact of trends in a variety of demographic and epidemiological factors on future services, and is also useful to physicians when considering the impact of new treatment strategies or programmes to modify risk factors for diabetic complications. |
| | |
Authors:
|
A Bagust; P K Hopkinson; W Maier; C J Currie |
Related Documents
:
|
20350145 - Cost-effectiveness of switching to biphasic insulin aspart from human premix insulin in... 17257715 - An assessment of the external radiological impact in areas of greece with elevated natu... 20191325 - The economic consequences of diabetes and cardiovascular disease in the united states. 1616295 - Net mechanical efficiency during stepping in chronically energy-deficient human subjects. 21273495 - The cost-effectiveness of personalized genetic medicine: the case of genetic testing in... 12637795 - Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Diabetologia Volume: 44 ISSN: 0012-186X ISO Abbreviation: Diabetologia Publication Date: 2001 Dec |
Date Detail:
|
Created Date: 2002-01-16 Completed Date: 2002-04-01 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0006777 Medline TA: Diabetologia Country: Germany |
Other Details:
|
Languages: eng Pagination: 2140-55 Citation Subset: IM |
Affiliation:
|
York Health Economics Consortium, University of York, Heslington, York, YO10 5DD, UK. ab13@york.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Diabetes Mellitus, Type 2 / complications, therapy* Diabetic Angiopathies / therapy Female Great Britain Health Care Costs* Humans Longevity Male Middle Aged Models, Economic* Morbidity Time Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Changes in physical activity are associated with changes in metabolic cardiovascular risk factors.
Next Document: Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 pro...